Deal adds an experimental drug for moderate to severe atopic dermatitis, building up AbbVie's core b...
AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion
Deal adds an experimental drug for moderate to severe atopic dermatitis, building up AbbVie's core business.
Author: WSJ
Read Original Article